ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
5001 CIRG/TORI 010: first analysis of a randomized phase II trial of motesanib plus weekly paclitaxel (P) as first line therapy in HER2-negative metastatic breast cancer (MBC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)70893-6
◽
2009
◽
Vol 7
(2)
◽
pp. 260
Author(s):
M. Martin
◽
S. Hurvitz
◽
J. Kennedy
◽
J. Forbes
◽
H. Roché
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Weekly Paclitaxel
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Related Documents
Cited By
References
CIRG/TORI 010: 10-Month Analysis of a Randomized Phase II Trial of Motesanib Plus Weekly Paclitaxel as First Line Therapy in HER2-Negative Metastatic Breast Cancer (MBC).
10.1158/0008-5472.sabcs-09-47
◽
2009
◽
Cited By ~ 3
Author(s):
J. Mackey
◽
S. Hurvitz
◽
J. Crown
◽
J. Forbes
◽
H. Roché
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Weekly Paclitaxel
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.
10.1158/0008-5472.sabcs11-p1-14-01
◽
2011
◽
Author(s):
AD Seidman
◽
AK Conlin
◽
A Bach
◽
A Forero-Torres
◽
G Wright
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial
Annals of Oncology
◽
10.1093/annonc/mdg199
◽
2003
◽
Vol 14
(5)
◽
pp. 699-703
◽
Cited By ~ 5
Author(s):
I. Elomaa
◽
H. Joensuu
◽
C. Blomqvist
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Phase II Trial of Capecitabine and Weekly Paclitaxel as First-Line Therapy for Metastatic Breast Cancer
Breast Diseases A Year Book Quarterly
◽
10.1016/s1043-321x(07)80275-x
◽
2007
◽
Vol 18
(2)
◽
pp. 204
Author(s):
W.J. Gradishar
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Weekly Paclitaxel
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer
The Oncologist
◽
10.1634/theoncologist.7-5-410
◽
2002
◽
Vol 7
(5)
◽
pp. 410-417
◽
Cited By ~ 107
Author(s):
Mohammad Jahanzeb
◽
Joanne E. Mortimer
◽
Furhan Yunus
◽
David H. Irwin
◽
James Speyer
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Docetaxel versus epirubicin/cyclophosphamide (EC) as first-line therapy in metastatic breast cancer (MBC): Results from the randomized phase II TIPP study
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.823
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 823-823
Author(s):
C. Wasemann
◽
A. Ertan
◽
C. Strunck
◽
W. Schmidt
◽
K. Diedrich
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.3080
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 3080-3080
◽
Cited By ~ 4
Author(s):
F. Ciardiello
◽
T. Troiani
◽
F. Caputo
◽
M. de Laurentiis
◽
G. Tortora
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)
Clinical Breast Cancer
◽
10.3816/cbc.2010.n.040
◽
2010
◽
Vol 10
(4)
◽
pp. 307-312
◽
Cited By ~ 8
Author(s):
Sara A. Hurvitz
◽
Heather J. Allen
◽
Rebecca L. Moroose
◽
David Chan
◽
Christopher Hagenstad
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
Breast Cancer Research and Treatment
◽
10.1007/s10549-006-9306-9
◽
2006
◽
Vol 101
(3)
◽
pp. 355-365
◽
Cited By ~ 92
Author(s):
Giampietro Gasparini
◽
Massimo Gion
◽
Luigi Mariani
◽
Paola Papaldo
◽
Diana Crivellari
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Weekly Paclitaxel
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
◽
Her 2
Download Full-text
First-line therapy with metronomic capecitabine (mC) plus docetaxel (D) followed by mC as maintenance for patients with HER2-negative metastatic breast cancer (MBC): Preliminary analysis of a monocentric phase II trial.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.e11547
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. e11547-e11547
◽
Cited By ~ 1
Author(s):
G. Aurilio
◽
A. Sciandivasci
◽
E. Munzone
◽
D. F. Riva
◽
D. Radice
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Preliminary Analysis
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close